W
NVO

WealthCollab’s Novo Nordisk NVO Stock Holding History

WealthCollab’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5K Sell
421
-117
-22% -$5.54K 0.01% 437
2025
Q4 		$27.4K Buy
538
+260
+94% +$13.3K 0.01% 316
2025
Q3 		$15.4K Sell
278
-194
-41% -$11.4K 0.01% 420
2025
Q2 		$32.6K Sell
472
-126
-21% -$8.57K 0.02% 237
2025
Q1 		$41.5K Sell
598
-155
-21% -$12.8K 0.03% 187
2024
Q4 		$64.8K Sell
753
-107
-12% -$11.6K 0.04% 134
2024
Q3 		$102K Hold
860
– – 0.07% 102
2024
Q2 		$123K Hold
860
– – 0.09% 78
2024
Q1 		$110K Buy
860
+6
+0.7% +$714 0.08% 83
2023
Q4 		$88.3K Buy
+854
New +$84.5K 0.07% 95

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WealthCollab's NVO Position: Q1 2026 in Review

WealthCollab reduced its Novo Nordisk (NVO) stake by 22% in Q1 2026, selling an estimated $5.54K and leaving 421 shares worth $15.5K. The position accounts for 0.01% of the portfolio, ranked #437.

WealthCollab first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $123K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • WealthCollab held 421 shares of Novo Nordisk worth $15.5K as of Q1 2026.
  • WealthCollab sold 117 Novo Nordisk shares in Q1 2026, an estimated $5.54K.
  • Novo Nordisk made up 0.01% of WealthCollab's portfolio in Q1 2026, its #437 holding.
  • WealthCollab first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Novo Nordisk position peaked at $123K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.